CO5580751A2 - Nueva formulacion de jarabe de epinastina seco y acuoso - Google Patents
Nueva formulacion de jarabe de epinastina seco y acuosoInfo
- Publication number
- CO5580751A2 CO5580751A2 CO04042457A CO04042457A CO5580751A2 CO 5580751 A2 CO5580751 A2 CO 5580751A2 CO 04042457 A CO04042457 A CO 04042457A CO 04042457 A CO04042457 A CO 04042457A CO 5580751 A2 CO5580751 A2 CO 5580751A2
- Authority
- CO
- Colombia
- Prior art keywords
- mask
- powder formulation
- pharmaceutical powder
- acid
- formulation according
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/14—Decongestants or antiallergics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
- A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE10152973A DE10152973A1 (de) | 2001-10-26 | 2001-10-26 | Neue trockene und wässrige Epinastin-Sirup-Formulierung |
Publications (1)
Publication Number | Publication Date |
---|---|
CO5580751A2 true CO5580751A2 (es) | 2005-11-30 |
Family
ID=7703856
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CO04042457A CO5580751A2 (es) | 2001-10-26 | 2004-05-07 | Nueva formulacion de jarabe de epinastina seco y acuoso |
Country Status (9)
Country | Link |
---|---|
EP (1) | EP1448204A1 (de) |
JP (2) | JP4564749B2 (de) |
KR (1) | KR20050034619A (de) |
BR (1) | BR0213488A (de) |
CO (1) | CO5580751A2 (de) |
DE (1) | DE10152973A1 (de) |
EC (1) | ECSP045087A (de) |
MX (1) | MXPA04003772A (de) |
WO (1) | WO2003037350A1 (de) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1452177A1 (de) * | 2003-02-27 | 2004-09-01 | Boehringer Ingelheim International GmbH | Pharmazeutische Zusammensetzungen welche Natriumlaurylsulfat als Bitterkeits-maskierenden Stoff enthalten |
US20040247686A1 (en) * | 2003-04-04 | 2004-12-09 | Boehringer Ingelheim International Gmbh | Pharmaceutical compositions comprising epinastine for the treatment of skin diseases |
WO2005089803A2 (en) * | 2004-03-24 | 2005-09-29 | Boehringer Ingelheim International Gmbh | Pharmaceutical compositions for the treatment of skin diseases comprising a combination of epinastine and one or more additional minerals or one or more crude drugs |
JP5132090B2 (ja) * | 2006-06-16 | 2013-01-30 | 東和薬品株式会社 | 塩酸エピナスチンドライシロップ剤 |
CN105708808B (zh) * | 2014-12-01 | 2018-11-27 | 重庆安格龙翔医药科技有限公司 | 一种盐酸依匹斯汀颗粒剂及其制备方法 |
CN105708840A (zh) * | 2014-12-01 | 2016-06-29 | 重庆安格龙翔医药科技有限公司 | 一种盐酸依匹斯汀组合物 |
CN105708807B (zh) * | 2014-12-01 | 2018-11-27 | 重庆安格龙翔医药科技有限公司 | 一种盐酸依匹斯汀细粒剂的制备方法 |
JP2020172486A (ja) * | 2019-04-10 | 2020-10-22 | 参天製薬株式会社 | エピナスチン又はその塩を含有する水性医薬組成物 |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3008944A1 (de) * | 1980-03-08 | 1981-09-24 | C.H. Boehringer Sohn, 6507 Ingelheim | Dibenzimidazoazepine, ihre herstellung und verwendung |
EP0658340A1 (de) * | 1993-12-17 | 1995-06-21 | Unilever N.V. | Orale Zusammensetzungen |
JPH0827034A (ja) * | 1994-07-14 | 1996-01-30 | Nikken Chem Co Ltd | エリスリトール含有内用液剤 |
JPH0952849A (ja) * | 1995-06-06 | 1997-02-25 | Taisho Pharmaceut Co Ltd | 感冒剤用組成物 |
DE19542281C2 (de) * | 1995-11-14 | 1997-12-04 | Boehringer Ingelheim Kg | Verwendung von Epinastin für die Behandlung der Migräne |
JPH1045576A (ja) * | 1996-08-05 | 1998-02-17 | Taisho Pharmaceut Co Ltd | 鼻炎用内服薬 |
AU9187598A (en) * | 1997-09-30 | 1999-04-23 | Daiichi Pharmaceutical Co., Ltd. | Oral preparation |
JPH11302189A (ja) * | 1998-04-21 | 1999-11-02 | Taisho Pharmaceut Co Ltd | 感冒用組成物 |
JP4731777B2 (ja) * | 1999-10-12 | 2011-07-27 | マルホ株式会社 | 経口医薬組成物 |
-
2001
- 2001-10-26 DE DE10152973A patent/DE10152973A1/de not_active Withdrawn
-
2002
- 2002-10-08 JP JP2003539693A patent/JP4564749B2/ja not_active Expired - Lifetime
- 2002-10-08 KR KR1020047006205A patent/KR20050034619A/ko not_active Application Discontinuation
- 2002-10-08 EP EP02802290A patent/EP1448204A1/de not_active Withdrawn
- 2002-10-08 WO PCT/EP2002/011250 patent/WO2003037350A1/en not_active Application Discontinuation
- 2002-10-08 MX MXPA04003772A patent/MXPA04003772A/es unknown
- 2002-10-08 BR BR0213488-8A patent/BR0213488A/pt not_active Application Discontinuation
-
2004
- 2004-04-26 EC EC2004005087A patent/ECSP045087A/es unknown
- 2004-05-07 CO CO04042457A patent/CO5580751A2/es not_active Application Discontinuation
-
2010
- 2010-03-02 JP JP2010044902A patent/JP2010132702A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
EP1448204A1 (de) | 2004-08-25 |
JP2010132702A (ja) | 2010-06-17 |
BR0213488A (pt) | 2004-11-03 |
DE10152973A1 (de) | 2003-05-08 |
JP4564749B2 (ja) | 2010-10-20 |
MXPA04003772A (es) | 2004-07-30 |
KR20050034619A (ko) | 2005-04-14 |
WO2003037350A1 (en) | 2003-05-08 |
ECSP045087A (es) | 2004-06-28 |
JP2005508364A (ja) | 2005-03-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES2537334T3 (es) | Formulación farmacéutica líquida para suministrar nicotina en la cavidad oral del sujeto | |
RU2000127710A (ru) | Твердая быстроразлагающаяся шипучая композиция для орального применения и способ ее получения | |
ES2224634T3 (es) | Formulacion oral que comprende biguanida y un acido organico. | |
JP2014509645A5 (de) | ||
CO5580751A2 (es) | Nueva formulacion de jarabe de epinastina seco y acuoso | |
HRP20161228T1 (hr) | Vrećica s nikotinom u obliku slobodne soli | |
JP2009517384A5 (de) | ||
AR073793A1 (es) | Formulacion farmaceutica liquida que contiene paracetamol. excipiente liquido | |
AR069128A1 (es) | Forma de dosificacion que se desintegra oralmente y proceso de preparacion | |
BR9709452B1 (pt) | sistema de liberaÇço bucal na forma de uma pastilha degastÁvel. | |
BRPI0406996A (pt) | Formas de dosagem sólida via transmucosa oral sem açúcar e sua utilização | |
JP2018523635A5 (de) | ||
HRP20110482T1 (hr) | Sastavi koji sadrže nerameksan | |
JP2013540795A (ja) | 苦味のある薬物のための経口用医薬フィルム製剤 | |
ES2555462T3 (es) | Composiciones acuosas que comprenden arbekacina | |
EP2393478B1 (de) | Pharmazeutische zusammensetzung mit hoher bioverfügbarkeit und maskiertem geschmack und geruch | |
RU2016130051A (ru) | Жидкие композиции рацекадотрила | |
ES2224869A1 (es) | Composiciones farmaceuticas con actividad antibiotica. | |
ES2312921T3 (es) | Disolucion acuosa concentrada de ambroxol. | |
HRP20211247T1 (hr) | Pastila | |
LV12250B (en) | PHARMACEUTICAL COMPOSITIONS ON DICLOFENAKA BASE | |
ES2211546T3 (es) | Solucion oral de prucaloprida. | |
ES2215025T3 (es) | Formulacion farmaceutica efervescente, que contiene metamizol. | |
UY26925A1 (es) | Sistemas saborizantes para composiciones farmacéuticas y métodos para hacer dichas composiciones | |
ES2392967T3 (es) | Formulaciones mejoradas que contienen derivados de imidazol sustituido |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FA | Application withdrawn |